Proper reconstitution of lyophilized peptides is critical for maintaining molecular integrity, bioactivity, and accurate concentration control in laboratory experiments. As a long-acting growth-hormone-releasing hormone (GHRH) analog, CJC-1295 with Drug Affinity Complex (DAC) requires standardized aseptic handling and calibrated diluent addition to ensure reproducible results across in vitro and preclinical research models. This guide outlines the precise steps, concentration calculations, storage parameters, and chemical handling protocols required for CJC-1295 DAC in research settings.
Proper reconstitution of lyophilized peptides is critical for maintaining molecular integrity, bioactivity, and accurate concentration control in laboratory experiments. As a long-acting growth-hormone-releasing hormone (GHRH) analog, CJC-1295 with Drug Affinity Complex (DAC) requires standardized aseptic handling and calibrated diluent addition to ensure reproducible results across in vitro and preclinical research models. This guide outlines the precise steps, concentration calculations, storage parameters, and chemical handling protocols required for CJC-1295 DAC in research settings.
CJC-1295 with Drug Affinity Complex (DAC) is a synthetic 29-amino-acid peptide analog of endogenous growth-hormone-releasing hormone (GHRH). The chemical structure incorporates specific amino acid substitutions at positions 2, 8, 15, and 27 to enhance enzymatic resistance against dipeptidyl peptidase-IV (DPP-IV) degradation. What distinguishes CJC-1295 DAC from standard GHRH variants is the addition of a maleimido-propionic acid linker covalently attached to the C-terminal lysine residue.
In preclinical models, this maleimide functional group reacts bioconjugatively with free thiol groups on circulating serum albumin (specifically at the Cys34 residue). This covalent binding forms a stable peptide-albumin adduct, significantly extending the terminal half-life of the compound from minutes to several days. Studied as a long-acting growth-hormone-releasing hormone that sustains GH and downstream IGF-1 levels for tissue repair research, CJC-1295 DAC serves as a primary tool for investigating endocrine feedback loops, somatotroph axis stimulation, and cellular regeneration kinetics without the rapid clearance observed in unmodified GHRH sequences.
To perform a compliant and contaminant-free reconstitution of CJC-1295 DAC, research laboratories must utilize sterile equipment and high-purity reagents. Working inside a certified Class II laminar flow hood or biosafety cabinet minimizes the introduction of ambient bioburden and particulates into the reaction vessel.
The standard equipment assembly for a typical 2 mg or 5 mg lyophilized vial includes: 0.9% benzyl alcohol-preserved bacteriostatic water (or sterile water for injection for immediate single-use assays), 70% isopropyl alcohol prep pads, calibrated micropipettes with filter barrier tips (or low-dead-volume polypropylene syringes), sterile glass storage vials, and nitrile laboratory gloves. Adhering to strict environmental control prevents sample contamination and preserves the analytical integrity of the peptide lot.
Choosing the appropriate solvent for cjc-1295 dac reconstitution depends on the intended laboratory workflow and assay timeline. Bacteriostatic Water for Injection (USP), which contains 0.9% (9 mg/mL) benzyl alcohol as a bacteriostatic preservative, is the standard solvent for multi-dose laboratory stock solutions. The presence of benzyl alcohol inhibits bacterial proliferation, allowing the reconstituted solution to remain stable under refrigeration for up to 28 days during repeated sampling.
Conversely, Sterile Water for Injection (USP) or unpreserved phosphate-buffered saline (PBS) is recommended when benzyl alcohol could interfere with sensitive cell culture systems or downstream enzymatic assays. Unpreserved aqueous stock solutions must be utilized immediately upon reconstitution or divided into single-use aliquots to be frozen at -80°C. For detailed protocols on diluent selection and chemical compatibility, consult the PX1 guide to bacteriostatic water handling.
Prior to reconstitution, remove the lyophilized CJC-1295 DAC vial from cold storage (-20°C or 2–8°C) and allow it to equilibrate to room temperature (20–25°C) inside a desiccator or sealed container for 20 to 30 minutes. Equilibrating the vial prevents condensation from forming on the inside walls upon opening, which could disrupt the precise mass measurement of the cake.
Clean the rubber septum of the peptide vial and the top of the diluent vial with a fresh 70% isopropyl alcohol wipe and allow them to air dry completely. Draw the precise volume of diluent (typically 1.0 mL to 2.0 mL per vial) into a calibrated sterile syringe or micropipette. Carefully insert the needle or tip through the center of the rubber stopper at a 45-degree angle to minimize core shedding.
Direct the stream of diluent down the glass wall of the vial rather than shooting it directly onto the lyophilized peptide cake. Forcing liquid directly onto the lyophilizate under high velocity can disrupt tertiary structural interactions and induce physical aggregation or excessive foaming. Allow the liquid to flow slowly down the side, submerging the solid material.
Swirl the vial gently in a circular horizontal motion across the benchtop. Do not shake, vortex, or invert the vial violently, as shear stress can cause protein denaturation or precipitation. Allow the vial to stand at room temperature for 5 to 10 minutes until the lyophilized cake fully dissolves into a crystal-clear, colorless solution.
Accurate concentration calculations are vital for maintaining protocol consistency across in vitro assays and animal model administrations. The standard equation $C_1 V_1 = C_2 V_2$ governs stock preparation and working dilution steps, where $C$ represents concentration and $V$ represents volume.
For a standard 2 mg (2,000 mcg) vial of CJC-1295 DAC reconstituted with 1.0 mL (1,000 µL) of Bacteriostatic Water, the resulting stock concentration is calculated as follows: $$\text{Concentration} = \frac{2,000\text{ mcg}}{1,000\text{ }\mu\text{L}} = 2.0\text{ mcg/}\mu\text{L}\text{ (or }2.0\text{ mg/mL)}$$ If a researcher adds 2.0 mL of diluent to a 2 mg vial, the resulting stock concentration is $1.0\text{ mcg/}\mu\text{L}$ ($1.0\text{ mg/mL}$).
For a 5 mg (5,000 mcg) vial of CJC-1295 DAC reconstituted with 2.5 mL of diluent, the final stock concentration is $2.0\text{ mcg/}\mu\text{L}$. If an assay requires a working dose of 100 mcg per treatment wells, pipetting $50\text{ }\mu\text{L}$ of the $2.0\text{ mcg/}\mu\text{L}$ stock solution delivers the exact microgram mass target. Researchers can review additional calculation templates in our research library hub.
When evaluating growth hormone secretagogue receptor (GHSR) or GHRH receptor pathways, researchers often compare CJC-1295 DAC against related synthetic ligands. Understanding the structural and pharmacokinetic differences between these molecules is essential when designing experimental frameworks.
In contrast to CJC-1295 DAC, CJC-1295 No DAC (also known as Modified GRF 1-29) lacks the maleimido-propionic acid linker. Consequently, CJC-1295 No DAC exhibits a rapid plasma clearance in animal models with a half-life of approximately 30 minutes, producing acute GH release spikes. Similarly, Sermorelin represents the native 29-amino-acid sequence of GHRH without DPP-IV-resisting amino acid substitutions, resulting in an even shorter half-life of 8 to 12 minutes. Another specialized comparison includes Tesamorelin, a GHRH analog modified with a trans-3-hexenoic acid group optimized for metabolic and lipodystrophy research models. While all four peptides bind to the GHRH receptor, CJC-1295 DAC remains unique in its ability to sustain baseline elevation of downstream IGF-1 for multi-day observation windows.
Maintaining correct environmental controls ensures peptide stability and prevents enzymatic or hydrolytic degradation. Unreconstituted (lyophilized) CJC-1295 DAC powder should be stored in a freezer at -20°C for short-to-medium durations, or at -80°C for multi-year long-term storage. Under these conditions, desiccated lyophilized cakes remain stable for extended periods without significant loss of purity.
Once reconstituted with bacteriostatic water, the working stock solution must be kept refrigerated at 2°C to 8°C (36°F to 46°F). Reconstituted stock should not be subjected to repeated freeze-thaw cycles, as ice crystal formation can cleave peptide bonds and disrupt tertiary structure. If long-term storage of reconstituted CJC-1295 DAC is required without benzyl alcohol, aliquot the stock solution into low-binding microcentrifuge tubes and freeze immediately at -80°C. For comprehensive details on thermal boundaries and chemical stability, refer to our peptide storage and handling protocol.
In occasional laboratory scenarios, physical dissolution challenges may arise due to hydrophobic interactions, concentration saturation, or temperature mismatch. Understanding how to address these phenomena ensures reliable sample preparation without damaging the target molecule.
If the peptide solution remains cloudy or exhibits visible particulate matter after 10 minutes of gentle swirling, verify that the vial was allowed to fully reach room temperature prior to diluent injection. Cold diluent added to a cold lyophilized cake can slow dissolution kinetics. If turbidity persists, brief incubation at room temperature (up to 15 minutes) usually completes the process. Never heat the vial or use bath sonication on CJC-1295 DAC, as cavitation forces can shear the bioconjugate linker. Persistent solubility issues may indicate improper storage history or sub-standard raw material synthesis.
Reliable scientific research depends entirely on the chemical purity and structural fidelity of raw reagents. PX1 Research synthesizes all research peptides within state-of-the-art, ISO 17025-accredited and GMP-compliant facilities in the United States. Every batch of CJC-1295 DAC undergoes rigorous high-performance liquid chromatography (HPLC) to verify purity exceeding 98.0%, combined with mass spectrometry (MS) to confirm exact molecular weight.
In addition to sequence verification, every lot is subjected to chromogenic LAL assays to ensure endotoxin limits remain below strict research thresholds (<0.01 EU/mg). PX1 Research publishes batch-specific Certificates of Analysis (COAs) accessible for every order, guaranteeing total traceability. All orders ship same-day (Monday through Friday) directly from our centralized distribution facilities in California and Arizona. Scientific institutions requiring bulk quantities or custom synthesis lots can coordinate directly through our wholesale laboratory portal.
What is the recommended diluent for reconstituting CJC-1295 DAC?
Bacteriostatic Water for Injection (USP containing 0.9% benzyl alcohol) is the standard diluent for multi-use laboratory stock solutions. Sterile Water for Injection (USP) may be used for immediate single-use in vitro assays where benzyl alcohol could interfere with cell viability.
How much bacteriostatic water should be added to a 2 mg vial of CJC-1295 DAC?
Adding 1.0 mL of bacteriostatic water to a 2 mg (2,000 mcg) vial yields a concentration of 2.0 mcg/µL (2.0 mg/mL). Adding 2.0 mL yields a concentration of 1.0 mcg/µL (1.0 mg/mL), simplifying pipetting calculations for microplate assays.
How should reconstituted CJC-1295 DAC stock solutions be stored?
Reconstituted solutions containing bacteriostatic water should be stored in a lab refrigerator at 2°C to 8°C for up to 28 days. Unpreserved aqueous stock solutions should be single-use micro-aliquoted and stored at -80°C to avoid freeze-thaw cycles.
What is the main functional difference between CJC-1295 DAC and CJC-1295 No DAC?
CJC-1295 DAC contains a Drug Affinity Complex (maleimido-propionic acid linker) that covalently binds to serum albumin in vivo, extending its biological half-life significantly compared to CJC-1295 No DAC, which lacks this linker and clears rapidly.
Why should CJC-1295 DAC vials not be shaken during reconstitution?
Vigorous shaking or vortexing introduces shear stress and air bubbles that can denature the peptide sequence, disrupt the functional DAC linker moiety, or induce protein aggregation and precipitation.
What endotoxin controls are applied to PX1 Research CJC-1295 DAC?
PX1 Research subjects every batch to quantitative LAL endotoxin testing in ISO 17025 accredited testing facilities, enforcing strict endotoxin thresholds below 0.01 EU/mg to guarantee suitability for sensitive cell assays.
Can reconstituted CJC-1295 DAC be refrozen after thawing?
Repeated freeze-thaw cycles cause structural degradation and physical aggregation of the peptide chain. If long-term sub-zero storage is necessary, the stock solution must be split into single-use aliquots before initial freezing at -80°C.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.